Answers are grounded in this paper and cite their sources.
Dynamin-2 mutations are associated with Charcot-Marie-Tooth (CMT) neuropathy; however, how these mutations affect neuronal function in vivo remains unclear. Here, we generated a Drosophila model carrying a CRISPR/Cas9-mediated knock-in of the shi 549Δ3 mutation, corresponding to the human dynamin-2-551Δ3 variant, and examined its physiological and cellular consequences. The shi 549Δ3 mutants exhibited progressive motor impairment across multiple genetic conditions. At the neuromuscular junction, the mutation caused synaptic overgrowth accompanied by excessive microtubule stabilization, including increased Futsch-positive loop structures and bouton numbers. Genetic interaction analysis revealed that reduction of Patronin, the Drosophila homolog of mammalian CAMSAPs, partially suppressed lethality and motor defects, linking microtubule stabilization to neuronal dysfunction in vivo . Consistently, CAMSAP2 knockdown in mammalian cells attenuated dynamin-2-induced microtubule acetylation, supporting a conserved mechanism. Together, these findings identify dysregulated microtubule stabilization as a key mechanism underlying neuropathy-like phenotypes caused by a CMT-associated dynamin mutation in vivo .
No takes yet. Share an insight, caveat, or question.
Miki et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: